Original Research
Published on 06 Aug 2021
CD86 Molecule Might Be a Novel Immune-Related Prognostic Biomarker for Patients With Bladder Cancer by Bioinformatics and Experimental Assays
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2021.679851
- 4,799 views
- 6 citations


